Nasal Flu Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Trivalent Flu Vaccine, and Quadrivalent Flu Vaccine); End Use (Hospitals, Clinics, and Others), and Geography

Report Code: TIPRE00022328 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Nasal Flu Vaccine stimulates the immune system and helps to prevent influenza in people. According to World Health Organization (WHO) reports, many individuals are admitted to hospitals due to influenza (commonly known as flu), and some of them die from it each year. Due to the non-invasive nature, simplified administration, and high immunization potential, nasal vaccines are rapidly becoming more viable alternatives to other routes of vaccine administration. The government initiatives to provide flu vaccines to children and the growing awareness about flu vaccines in the developing economies and underdeveloped economies are speculated to offer lucrative opportunities in the market.

MARKET SCOPE

The "Global Nasal Flu Vaccine Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the nasal flu vaccine market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading nasal flu vaccine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
  •  Based on type, the global nasal flu vaccine market is segmented into trivalent flu vaccine, quadrivalent flu vaccine.
  •  On the basis of end use, the market is segmented into hospitals, clinics, others.

MARKET DYNAMICS

Drivers-
  •   Rise in the incidences of several respiratory infections.
  •   Ongoing corona virus epidemic.
  •   Amplifies patient compliance and better absorption.
Restraints-
  •   Some of the side effects of nasal flu vaccine are the major restraining factors for this market.
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The nasal flu vaccine market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the nasal flu vaccine market in these regions.

IMPACT OF COVID-19 ON NASAL FLU VACCINE MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Despite of all of these hurdles, Nasal Flu Vaccine Market is in demand due to COVID-19.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the nasal flu vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from nasal flu vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for nasal flu vaccine in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the nasal flu vaccine market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •  GlaxoSmithKline Plc
  •  Sanofi
  •  Abbott
  •  AstraZeneca
  •  Serum Institute of India Pvt. Ltd.
  •  CSL Ltd
  •  Bharat Biotech
  •  Antares Pharma
  •  INJEX Pharma GmbH
  •  BioDiem
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nasal Flu Vaccine Market - By Type
1.3.2 Nasal Flu Vaccine Market - By End Use
1.3.3 Nasal Flu Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NASAL FLU VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NASAL FLU VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NASAL FLU VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. NASAL FLU VACCINE - GLOBAL MARKET OVERVIEW
6.2. NASAL FLU VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NASAL FLU VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRIVALENT FLU VACCINE
7.3.1. Overview
7.3.2. Trivalent Flu Vaccine Market Forecast and Analysis
7.4. QUADRIVALENT FLU VACCINE
7.4.1. Overview
7.4.2. Quadrivalent Flu Vaccine Market Forecast and Analysis
8. NASAL FLU VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. NASAL FLU VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Nasal Flu Vaccine Market Overview
9.1.2 North America Nasal Flu Vaccine Market Forecasts and Analysis
9.1.3 North America Nasal Flu Vaccine Market Forecasts and Analysis - By Type
9.1.4 North America Nasal Flu Vaccine Market Forecasts and Analysis - By End Use
9.1.5 North America Nasal Flu Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Nasal Flu Vaccine Market
9.1.5.1.1 United States Nasal Flu Vaccine Market by Type
9.1.5.1.2 United States Nasal Flu Vaccine Market by End Use
9.1.5.2 Canada Nasal Flu Vaccine Market
9.1.5.2.1 Canada Nasal Flu Vaccine Market by Type
9.1.5.2.2 Canada Nasal Flu Vaccine Market by End Use
9.1.5.3 Mexico Nasal Flu Vaccine Market
9.1.5.3.1 Mexico Nasal Flu Vaccine Market by Type
9.1.5.3.2 Mexico Nasal Flu Vaccine Market by End Use
9.2. EUROPE
9.2.1 Europe Nasal Flu Vaccine Market Overview
9.2.2 Europe Nasal Flu Vaccine Market Forecasts and Analysis
9.2.3 Europe Nasal Flu Vaccine Market Forecasts and Analysis - By Type
9.2.4 Europe Nasal Flu Vaccine Market Forecasts and Analysis - By End Use
9.2.5 Europe Nasal Flu Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Nasal Flu Vaccine Market
9.2.5.1.1 Germany Nasal Flu Vaccine Market by Type
9.2.5.1.2 Germany Nasal Flu Vaccine Market by End Use
9.2.5.2 France Nasal Flu Vaccine Market
9.2.5.2.1 France Nasal Flu Vaccine Market by Type
9.2.5.2.2 France Nasal Flu Vaccine Market by End Use
9.2.5.3 Italy Nasal Flu Vaccine Market
9.2.5.3.1 Italy Nasal Flu Vaccine Market by Type
9.2.5.3.2 Italy Nasal Flu Vaccine Market by End Use
9.2.5.4 Spain Nasal Flu Vaccine Market
9.2.5.4.1 Spain Nasal Flu Vaccine Market by Type
9.2.5.4.2 Spain Nasal Flu Vaccine Market by End Use
9.2.5.5 United Kingdom Nasal Flu Vaccine Market
9.2.5.5.1 United Kingdom Nasal Flu Vaccine Market by Type
9.2.5.5.2 United Kingdom Nasal Flu Vaccine Market by End Use
9.2.5.6 Rest of Europe Nasal Flu Vaccine Market
9.2.5.6.1 Rest of Europe Nasal Flu Vaccine Market by Type
9.2.5.6.2 Rest of Europe Nasal Flu Vaccine Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Nasal Flu Vaccine Market Overview
9.3.2 Asia-Pacific Nasal Flu Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Nasal Flu Vaccine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Nasal Flu Vaccine Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Nasal Flu Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Nasal Flu Vaccine Market
9.3.5.1.1 Australia Nasal Flu Vaccine Market by Type
9.3.5.1.2 Australia Nasal Flu Vaccine Market by End Use
9.3.5.2 China Nasal Flu Vaccine Market
9.3.5.2.1 China Nasal Flu Vaccine Market by Type
9.3.5.2.2 China Nasal Flu Vaccine Market by End Use
9.3.5.3 India Nasal Flu Vaccine Market
9.3.5.3.1 India Nasal Flu Vaccine Market by Type
9.3.5.3.2 India Nasal Flu Vaccine Market by End Use
9.3.5.4 Japan Nasal Flu Vaccine Market
9.3.5.4.1 Japan Nasal Flu Vaccine Market by Type
9.3.5.4.2 Japan Nasal Flu Vaccine Market by End Use
9.3.5.5 South Korea Nasal Flu Vaccine Market
9.3.5.5.1 South Korea Nasal Flu Vaccine Market by Type
9.3.5.5.2 South Korea Nasal Flu Vaccine Market by End Use
9.3.5.6 Rest of Asia-Pacific Nasal Flu Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Nasal Flu Vaccine Market by Type
9.3.5.6.2 Rest of Asia-Pacific Nasal Flu Vaccine Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Nasal Flu Vaccine Market Overview
9.4.2 Middle East and Africa Nasal Flu Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Nasal Flu Vaccine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Nasal Flu Vaccine Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Nasal Flu Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Nasal Flu Vaccine Market
9.4.5.1.1 South Africa Nasal Flu Vaccine Market by Type
9.4.5.1.2 South Africa Nasal Flu Vaccine Market by End Use
9.4.5.2 Saudi Arabia Nasal Flu Vaccine Market
9.4.5.2.1 Saudi Arabia Nasal Flu Vaccine Market by Type
9.4.5.2.2 Saudi Arabia Nasal Flu Vaccine Market by End Use
9.4.5.3 U.A.E Nasal Flu Vaccine Market
9.4.5.3.1 U.A.E Nasal Flu Vaccine Market by Type
9.4.5.3.2 U.A.E Nasal Flu Vaccine Market by End Use
9.4.5.4 Rest of Middle East and Africa Nasal Flu Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Nasal Flu Vaccine Market by Type
9.4.5.4.2 Rest of Middle East and Africa Nasal Flu Vaccine Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Nasal Flu Vaccine Market Overview
9.5.2 South and Central America Nasal Flu Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Nasal Flu Vaccine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Nasal Flu Vaccine Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Nasal Flu Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Nasal Flu Vaccine Market
9.5.5.1.1 Brazil Nasal Flu Vaccine Market by Type
9.5.5.1.2 Brazil Nasal Flu Vaccine Market by End Use
9.5.5.2 Argentina Nasal Flu Vaccine Market
9.5.5.2.1 Argentina Nasal Flu Vaccine Market by Type
9.5.5.2.2 Argentina Nasal Flu Vaccine Market by End Use
9.5.5.3 Rest of South and Central America Nasal Flu Vaccine Market
9.5.5.3.1 Rest of South and Central America Nasal Flu Vaccine Market by Type
9.5.5.3.2 Rest of South and Central America Nasal Flu Vaccine Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NASAL FLU VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NASAL FLU VACCINE MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBOTT
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SERUM INSTITUTE OF INDIA PVT. LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CSL LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BHARAT BIOTECH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ANTARES PHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. INJEX PHARMA GMBH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIODIEM
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline Plc
2. Sanofi
3. Abbott
4. AstraZeneca
5. Serum Institute of India Pvt. Ltd.
6. CSL Ltd
7. Bharat Biotech
8. Antares Pharma
9. INJEX Pharma GmbH
10. BioDiem
11. PharmaJet
12. Crossject
TIPRE00022328
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking